During the past decade, Providence Arthritis Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Arthritis Center" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Providence Arthritis Center" are "Rheumatoid Arthritis" (3 trials). Many other conditions were trialed in "Providence Arthritis Center" in a lesser frequency.

Most popular intervention types in "Providence Arthritis Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Ocrelizumab" (2 trials), "Placebo" (2 trials), "HuMax-CD4" (1 trials) and "Infliximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Providence Arthritis Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Providence Arthritis Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Providence Arthritis Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Arthritis Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".